| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.2174/156652305774964758 |
| P8608 | Fatcat ID | release_n6suoqvq7vczjedkyllcxrizha |
| P698 | PubMed publication ID | 16457651 |
| P5875 | ResearchGate publication ID | 7315904 |
| P2093 | author name string | Antoni Ribas | |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunotherapy | Q1427096 |
| dendritic cell | Q506253 | ||
| P304 | page(s) | 619-628 | |
| P577 | publication date | 2005-12-01 | |
| P1433 | published in | Current Gene Therapy | Q5195046 |
| P1476 | title | Genetically modified dendritic cells for cancer immunotherapy | |
| P478 | volume | 5 |
| Q34814931 | A dystrophic muscle broadens the contribution and activation of immune cells reacting to rAAV gene transfer |
| Q56967539 | Activated B cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigen-specific T-cell responses |
| Q37773259 | Dendritic cell-based vaccines for the therapy of experimental tumors |
| Q37621566 | Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification. |
| Q43136029 | Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases |
| Q34443707 | Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy |
| Q37127252 | Gene-modified bone marrow cell therapy for prostate cancer |
| Q37800934 | Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow? |
| Q36563145 | HER2-specific T lymphocytes kill both trastuzumab-resistant and trastuzumab-sensitive breast cell lines in vitro |
| Q44408019 | Improvement of HBsAg gene-modified dendritic cell-based vaccine efficacy by optimizing immunization method or the application of β-glucosylceramide |
| Q35186003 | Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells |
| Q37706590 | Lentiviral vectors for immunization: an inflammatory field |
| Q36031874 | Lentivirus-induced 'Smart' dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma |
| Q55292718 | Lipid Accumulation in Peripheral Blood Dendritic Cells and Anticancer Immunity in Patients with Lung Cancer. |
| Q60196643 | Modelos experimentais em oncologia: O contributo da cultura de células para o conhecimento da biologia do cancro |
| Q37693733 | Personalized dendritic cell-based tumor immunotherapy |
| Q46494054 | Potential of immunotherapy for sarcoma |
| Q43186978 | Preparation of cationized polysaccharides as gene transfection carrier for bone marrow-derived mesenchymal stem cells |
| Q36765440 | Recent advances and current challenges in tumor immunology and immunotherapy. |
| Q39549087 | Recombinant monomeric CD40 ligand for delivering polymer particles to dendritic cells |
| Q40154358 | T-regulatory cells are relatively deficient in squamous carcinomas undergoing regression in mice immunized with a squamous carcinoma vaccine enriched for immunotherapeutic cells |
| Q58750585 | The Journey of Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road |
| Q38103222 | Tracking and evaluation of dendritic cell migration by cellular magnetic resonance imaging |
| Q42037581 | Transgene expression and local tissue distribution of naked and polymer-condensed plasmid DNA after intradermal administration in mice |
| Q33383239 | Urea-mediated cross-presentation of soluble Epstein-Barr virus BZLF1 protein |
| Q80521706 | mRNA-based cancer vaccine: prevention of B16 melanoma progression and metastasis by systemic injection of MART1 mRNA histidylated lipopolyplexes |
Search more.